Glibenclamide Attenuates Neuroinflammation and Promotes Neurological Recovery After Intracerebral Hemorrhage in Aged Rats

Intracerebral hemorrhage (ICH) is a common disease in the elderly population. Inflammation following ICH plays a detrimental role in secondary brain injury, which is associated with a poor prognosis of patients with ICH, and no efficient pharmacological preventions are available. Here, we investigated the effects of glibenclamide (GLC) on neuroinflammation in an autoblood-induced aged rat (18 months old) model of ICH. Rats were randomized into the sham, vehicle, and GLC groups. First, we investigated the expression level of sulfonylurea receptor 1 (Sur1) surrounding the hematoma after ICH. Then, neurological scores were calculated, and water maze tests, brain water content analysis, western blotting, and immunofluorescence assays were implemented to detect the neuroprotective effect of GLC. The expression of the Sur1-Trpm4 channel was significantly increased in the perihematomal tissue following ICH in aged rats. The GLC administration effectively reduced brain edema and improved neurofunction deficits following ICH. In addition, GLC increased the expression of brain-derived neurotrophic factors and decreased the expression of proinflammatory factors [tumor necrosis factor (TNF)-alpha,interleukin (IL)-1, and IL-6]. Moreover, GLC markedly reduced Ikappa-B (I kappa B) kinase (IKK) expression in microglia and nuclear factor (NF)-kappa B-P65 levels in perihematomal tissue. GLC ameliorated ICH-induced neuroinflammation and improved neurological outcomes in aged rats. In part, GLC may exert these effects by regulating the NF-kappa B signaling pathway through the Sur1-Trpm4 channel.

Automated summary

The study shows that GLC can effectively reduce brain edema, improve neurofunction deficits after ICH, increase brain-derived neurotrophic factors, and decrease proinflammatory factors. GLC reduces IKK expression in microglia and NF-κB-P65 levels in perihematomal tissue. GLC alleviates ICH-induced neuroinflammation and improves neurological outcomes in aged rats by regulating the NF-κB signaling pathway through the Sur1-Trpm4 channel.